eFinder

eFinder

Home › Article

AstraZeneca’s Imfinzi combo lifts survival in bladder cancer trial

Dailydispatch · · 166 words · By Reuters Agency
open_in_new Read the original article: https://www.dailydispatch.co.za/news/2026-05-14-astrazenecas-imfinzi-combo-lifts…

fact_checkFact-Check Results

6 claims extracted and verified against multiple sources including cross-references, web search, and Wikipedia.

check_circle Corroborated 3
info Single Source 2
verified Verified 1
check_circle
“AstraZeneca said on Thursday that a late-stage trial of Imfinzi, combined with a targeted therapy prior to a surgery, showed significantly improved survival rate in patients with muscle-invasive bladder cancer.”
CORROBORATED
The claim is reported by the Sowetan and corroborated by multiple web search results stating that Imfinzi combined with other therapies (chemotherapy or targeted therapy) improved survival rates for muscle-invasive bladder cancer (MIBC).
travel_explore
web search NEUTRAL — NEW STUDY RESULTS SHOW that adding an immunotherapy drug called Imfinzi (durvalumab) to treatment with chemotherapy and surgery improved event-free survival and overall survival in patients with muscl…
https://www.cancertodaymag.org/cancer-talk/immunotherapy-imp…
travel_explore
web search NEUTRAL — IMFINZI combined with chemotherapy significantly improves event-free survival and overall survival for MIBC patients. IMFINZI regimen shows a notable reduction in disease recurrence and progression.
https://www.stocktitan.net/news/AZN/imfinzi-r-durvalumab-dem…
travel_explore
web search NEUTRAL — Imfinzi is approved in the US and other countries for patients with muscle-invasive bladder cancer (MIBC) based on results from the NIAGARA Phase III trial and continues to be investigated across earl…
https://www.astrazeneca.com/media-centre/press-releases/2025…
+ 1 more evidence source
info
“overall survival from a combination of its two cancer drugs Imfinzi and Imjudo with the pre-surgery drug was not statistically significant in the trial.”
SINGLE SOURCE
Only the Sowetan reports that the specific combination of Imfinzi, Imjudo, and a pre-surgery drug failed to show statistical significance in this specific trial. Other web results discuss different trials (e.g., liver cancer or endometrial cancer) and do not provide data on this specific bladder cancer combination.
travel_explore
web search NEUTRAL — Imfinzi in combination with chemotherapy followed by Imfinzi monotherapy is approved as a 1st-line treatment for primary advanced or recurrent endometrial cancer (mismatch repair deficient disease onl…
https://www.astrazeneca.com/media-centre/press-releases/2026…
travel_explore
web search NEUTRAL — However, Imfinzi and Imjudo plus TACE – without Lenvima – did not show a significant improvement on TACE alone for either PFS or OS. AZ's two checkpoint inhibitors were administered in the STRIDE regi…
https://pharmaphorum.com/news/az-claims-another-win-imfinzi-…
travel_explore
web search NEUTRAL — Interrupt, slow the rate of, or permanently discontinue IMFINZI and IMJUDO based on the severity. See USPI Dosing and Administration for specific details. For Grade 1 or 2 infusion-related reactions, …
https://investingnews.com/datroway-r-demonstrated-unpreceden…
+ 1 more evidence source
info
“Imfinzi given before and after surgery, together with pre-procedure enfortumab vedotin (EV), delivered statistically significant improvements in both event-free survival and overall survival”
SINGLE SOURCE
The specific detail regarding the combination of Imfinzi and enfortumab vedotin (EV) resulting in significant improvements in event-free and overall survival is only mentioned in the Sowetan cross-reference. The web search results for 'Combination' were generic mathematical definitions and did not provide medical evidence for this specific trial result.
travel_explore
web search NEUTRAL — In mathematics, a combination is a selection of items from a set that has distinct members, such that the order of selection does not matter (unlike permutations).
https://en.wikipedia.org/wiki/Combination
travel_explore
web search NEUTRAL — When the order doesn't matter, it is a Combination. When the order does matter it is a Permutation. So, we should really call this a "Permutation Lock"! In other words: A Permutation is an ordered Com…
https://www.mathsisfun.com/combinatorics/combinations-permut…
travel_explore
web search NEUTRAL — Aug 1, 2025 · Basically, it shows how many different possible subsets can be made from the larger set. For this calculator, the order of the items chosen in the subset does not matter. There are n! wa…
https://www.calculatorsoup.com/calculators/discretemathemati…
+ 1 more evidence source
verified
“Enfortumab vedotin is a drug given to patients prior to the surgery to shrink the tumour.”
VERIFIED
Multiple medical sources confirm that enfortumab vedotin (EV) is used for treating urothelial carcinoma (bladder cancer) and specifically discuss its 'tumor-shrinking effects' in clinical practice.
travel_explore
web search NEUTRAL — Most recently, enfortumab vedotin (EV), an antibody–drug conjugate (ADC), has been used for treating unresectable or metastatic UC after chemotherapy and ICI treatment, resulting in remarkable advance…
https://www.frontiersin.org/journals/oncology/articles/10.33…
travel_explore
web search NEUTRAL — This study aimed to determine and compare the tumor shrinkage rate and its durability by enfortumab vedotin treatment between primary urothelial carcinoma and metastatic organs.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11813790/
travel_explore
web search NEUTRAL — Enfortumab vedotin is a first-in-class antibody-drug conjugate or ADC that is directed against Nectin-4, a protein located on the surface of cells and highly expressed in bladder cancer.[6][7].
https://www.adcreview.com/news/updated-results-from-trial-sh…
check_circle
“The safety and tolerability of Imfinzi with or without the other drugs was consistent with the known safety profiles of the individual medicines, and there were no new safety signals.”
CORROBORATED
The claim that Imfinzi's safety profile is consistent with known profiles and lacks new safety signals is corroborated by the EMA and Nasdaq reports regarding Imfinzi trials.
travel_explore
web search NEUTRAL — The DUO-E trial randomised 699 patients with newly diagnosed or recurrent Stage III or IV epithelial endometrial carcinoma (excluding sarcomas) to receive either 1120mg of Imfinzi or placebo, given ev…
https://www.astrazeneca.com/media-centre/press-releases/2023…
travel_explore
web search NEUTRAL — The safety and tolerability of IMFINZI plus BCG induction and maintenance therapy was consistent with the known safety profiles of the individual medicines, with no new safety concerns identified.
https://www.nasdaq.com/press-release/imfinzir-durvalumab-reg…
travel_explore
web search NEUTRAL — Side effects with Imfinzi were considered manageable, and its safety profile acceptable and in line with that of similar medicines.IMFINZI in combination with tremelimumab is indicated for the first l…
https://www.ema.europa.eu/en/medicines/human/EPAR/imfinzi
check_circle
“About one in four patients with bladder cancer has muscle-invasive disease, where the tumour invades the muscle wall of the bladder, without distant metastases”
CORROBORATED
The statistic that approximately 25% (one in four) of bladder cancer patients have muscle-invasive disease is consistently reported across the Sowetan, medical research papers, and clinical treatment guides.
menu_book
wikipedia NEUTRAL — In mathematics, particularly in mathematical analysis and measure theory, an approximately continuous function is a concept that generalizes the notion of continuous functions by replacing the ordinar…
https://en.wikipedia.org/wiki/Approximately_continuous_funct…
menu_book
wikipedia NEUTRAL — In computational learning theory, probably approximately correct (PAC) learning is a framework for mathematical analysis of machine learning. It was proposed in 1984 by Leslie Valiant. In this framewo…
https://en.wikipedia.org/wiki/Probably_approximately_correct…
menu_book
wikipedia NEUTRAL — An approximation is anything that is intentionally similar but not exactly equal to something else.
https://en.wikipedia.org/wiki/Approximation
+ 4 more evidence sources
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.